Piloting a Deaf Accessible Pre-Treatment for AUD

Part of paid clinical trials in Shrewsbury, Massachusetts.

Sponsor
University of Massachusetts, Worcester
Study ID
NCT07269119
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Deaf-MET — BEHAVIORAL
    Deaf-MET is a culturally and linguistically accessible adaptation of Motivational Enhancement Therapy (MET) for Deaf adults with high-risk alcohol use

Study Details

This pilot study will evaluate the feasibility, acceptability, and preliminary efficacy of an adaptation of Motivational Enhancement Therapy (MET) titled "DeafMET", intended for Deaf adults with high-risk alcohol use. In this single intervention cycle, 10 Deaf participants will receive the DeafMET intervention delivered either in-person or via telehealth. Primary outcomes include change in participants' stage of change regarding alcohol use and measures of recruitment, retention, satisfaction, and adherence. Findings will inform further refinement of the intervention and planning for future research.

Key Dates

Start date
Feb 5, 2026
Status verified
Feb 2026
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Experimental Arm: Deaf-MET Intervention
    Participants in the experimental arm will receive Deaf-MET, a culturally and linguistically accessible adaptation of Motivational Enhancement Therapy (MET) for Deaf adults with high-risk alcohol use. MET is a client-centered counseling approach that enhances motivation for change by exploring and resolving ambivalence, using reflective listening, feedback, and collaborative goal-setting. Deaf-MET will be delivered in American Sign Language and incorporates visual handouts, plain language materials, and filmed educational content adapted from the original MET protocol into ASL teaching stories. Sessions are offered in-person or via telehealth.

Primary Outcome Measure

University of Rhode Island Change Assessment [ Time Frame: From enrollment to end of participation at 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UMass ChanShrewsburyMassachusetts01545-

Find similar trials in Shrewsbury, MA

By condition
Substance use disorder
By specialty
Behavioral healthAddiction medicine
By research site
UMass Chan· Shrewsbury, MA

Related Studies